Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1998-05-15
2000-06-13
Salimi, Ali
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
4242291, 4241841, 4242051, 4352351, 4353201, 435236, 435351, 536 2372, 536 241, A61K 3912, A61K 39245, C12N 1500
Patent
active
060746491
ABSTRACT:
The recombinant live vaccine comprises, as vector, a feline herpesvirus comprising and expressing at least one nucleotide sequence encoding a polypeptide, this sequence being inserted into the ORF5 and/or ORF2 sites. Polyvalent vaccine formula and feline herpesvirus DNA fragments.
REFERENCES:
patent: 5652119 (1997-07-01), Willemse et al.
Willemse et al. Vaccine, 1996, vol. 14, No. 16, pp. 1511-1516.
Willemse et al., "The Gene Downstream of the gC Homologue in Feline Herpes Virus Type I Is Involved in the Expression of Virulence," Journal of General Virology (1994), vol. 75, pp. 3107-3116.
Wardley et al., "The Use of Feline Herpesvirus and Baculovirus as Vaccine Vectors for the GAG and ENV Genes of Feline Leukemia Virus," Journal of General Virology (1992), vol. 73, pp. 1811-1818.
Audonnet Jean-Christophe Francis
Baudu Philippe Guy Nicolas
Riviere Michel Albert Emile
Frommer William S.
Kowalski Thomas J.
Merial
Salimi Ali
LandOfFree
Recombinant composition containing feline herpes virus type 1, p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant composition containing feline herpes virus type 1, p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant composition containing feline herpes virus type 1, p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2066285